Deferred Tax Assets, Net of Valuation Allowance of Core Laboratories Inc. /DE/ from 31 Dec 2022 to 31 Dec 2024

Taxonomy & unit
us-gaap: USD
Description
Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.
Summary
Core Laboratories Inc. /DE/ quarterly Deferred Tax Assets, Net of Valuation Allowance in USD history and change rate from 31 Dec 2022 to 31 Dec 2024.
  • Core Laboratories Inc. /DE/ Deferred Tax Assets, Net of Valuation Allowance for the quarter ending 31 Dec 2024 was $71,689,000, a 0.02% decline year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Net of Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Net of Valuation Allowance, YoY Quarterly Change (%)

Core Laboratories Inc. /DE/ Quarterly Deferred Tax Assets, Net of Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2024 $71,689,000 -$11,000 -0.02% 31 Dec 2024 10-K 13 Feb 2025 2024 FY
Q4 2023 $71,700,000 -$5,750,000 -7.4% 31 Dec 2023 10-K 13 Feb 2025 2024 FY
Q4 2022 $77,450,000 31 Dec 2022 10-K 15 Feb 2024 2023 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.